1. Home
  2. VS vs CYCC Comparison

VS vs CYCC Comparison

Compare VS & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VS
  • CYCC
  • Stock Information
  • Founded
  • VS 2013
  • CYCC 1992
  • Country
  • VS United States
  • CYCC Malaysia
  • Employees
  • VS N/A
  • CYCC N/A
  • Industry
  • VS EDP Services
  • CYCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • VS Technology
  • CYCC Health Care
  • Exchange
  • VS Nasdaq
  • CYCC Nasdaq
  • Market Cap
  • VS 10.1M
  • CYCC 8.3M
  • IPO Year
  • VS N/A
  • CYCC N/A
  • Fundamental
  • Price
  • VS $2.53
  • CYCC $0.24
  • Analyst Decision
  • VS Hold
  • CYCC
  • Analyst Count
  • VS 1
  • CYCC 0
  • Target Price
  • VS $2.00
  • CYCC N/A
  • AVG Volume (30 Days)
  • VS 59.1K
  • CYCC 4.2M
  • Earning Date
  • VS 08-13-2025
  • CYCC 08-13-2025
  • Dividend Yield
  • VS N/A
  • CYCC N/A
  • EPS Growth
  • VS N/A
  • CYCC N/A
  • EPS
  • VS N/A
  • CYCC N/A
  • Revenue
  • VS $230,132.00
  • CYCC $14,000.00
  • Revenue This Year
  • VS $3,459.21
  • CYCC $137.21
  • Revenue Next Year
  • VS N/A
  • CYCC N/A
  • P/E Ratio
  • VS N/A
  • CYCC N/A
  • Revenue Growth
  • VS 64.71
  • CYCC N/A
  • 52 Week Low
  • VS $1.00
  • CYCC $0.22
  • 52 Week High
  • VS $9.59
  • CYCC $39.84
  • Technical
  • Relative Strength Index (RSI)
  • VS 57.08
  • CYCC 24.28
  • Support Level
  • VS $2.25
  • CYCC $0.31
  • Resistance Level
  • VS $2.44
  • CYCC $0.34
  • Average True Range (ATR)
  • VS 0.21
  • CYCC 0.05
  • MACD
  • VS 0.00
  • CYCC 0.10
  • Stochastic Oscillator
  • VS 60.33
  • CYCC 8.57

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.

Share on Social Networks: